ADMA Biologics (ADMA) S-8 POSRegistration of securities for employees (post-effective amendment)

Filed: 22 Jul 22, 4:32pm

Free signup for more

Track your favorite companies
Receive email alerts for new filings
Personalized dashboard of news and more
Access all data and search results

Search this filing

All

Tables only

Footnotes only

Pre-defined:

Table of contents

Filing tables

Export all tables to Excel

Filing exhibits

S-8 POS Registration of securities for employees (post-effective amendment)
5.1 Exhibit 5.1
23.2 Exhibit 23.2

ADMA similar filings

22 Jul 22 Registration of securities for employees (post-effective amendment)
22 Jul 22 Registration of securities for employees (post-effective amendment)
22 Jul 22 Registration of securities for employees (post-effective amendment)
22 Jul 22 Registration of securities for employees (post-effective amendment)

Filing view

Default size S M L
Default font Times Arial

External links

View on EDGAR (sec.gov)

Share this filing

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Post-Effective Amendment No.1 to the following Registration Statements:

(1)

Registration Statement (Form S-8 No. 333-204590) on May 29, 2015 to register 1,600,000 shares of Common Stock,

(2)

Registration Statement (Form S-8 No. 333-220058) on August 18, 2017 to register 2,000,000 shares of Common Stock,

(3)

Registration Statement (Form S-8 No. 333-224492) on April 27, 2018 to register 1,812,666 shares of Common Stock,

(4)

Registration Statement (Form S-8 No. 333-229921) on February 27, 2019 to register 1,854,122 shares of Common Stock,

(5)

Registration Statement (Form S-8 No. 333-237658) on April 13, 2020 to register 2,372,734 shares of Common Stock,

(6)

Registration Statement (Form S-8 No. 333-254770) on March 26, 2021 to register 3,491,134 shares of Common Stock, and

(7)

Registration Statement (Form S-8 No. 333-263345) on March 7, 2022 to register 7,832,552 shares of Common Stock;

of our report dated March 24, 2022, on our audits of the consolidated financial statements of the Company as of December 31, 2021 and 2020 and for the years then ended, which report is included in the Annual Report on Form 10-K of the Company for the year ended December 31, 2021.

/s/ CohnReznick LLP

Holmdel, New Jersey

July 22, 2022

Resources

Knowledgebase
Log In
Register

Company

About
Contact
Solutions

Products

Deal Roadshow
DealVDR
Evercall
Finsight.com

CapEdge

Earnings Calendar
Earnings Transcripts
EDGAR Filing Screener
IPO Calendar

Compliance
Privacy
Security
Terms

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.